Utah Medical Products announces Q1 2026 financial results; figures not available in filing

UTAH MEDICAL PRODUCTS INC

2026-Q1 EPS reported $0.82 revenue$8,722,000

Press release attached as Exhibit 99.1 includes Q1 2026 financial information and forward-looking statements.
Exact figures (revenue, EPS, etc.) are not available in the provided filing text excerpt.
Refer to the full exhibit for detailed performance data and guidance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.